Correlation between Multiparametric MR Imaging and Molecular Genetics in Pontine Pediatric High-Grade Glioma

被引:2
|
作者
Rameh, V. [1 ]
Vajapeyam, S. [1 ]
Ziaei, A. [1 ]
Kao, P. [2 ]
London, W. B. [2 ]
Baker, S. J. [3 ]
Chiang, J. [4 ,5 ]
Lucas, J.
Tinkle, C. L. [5 ]
Wright, K. D. [2 ]
Poussaint, T. Y. [1 ,6 ]
机构
[1] Harvard Med Sch, Boston Childrens Hosp, Dept Radiol, Boston, MA USA
[2] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA USA
[3] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN USA
[4] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN USA
[5] St Jude Childrens Res Hosp, Dept Radiat Oncol, Memphis, TN USA
[6] Boston Childrens Hosp, Dept Radiol, 300 Longwood Ave, Boston, MA 02115 USA
关键词
DIFFUSE MIDLINE GLIOMAS; CENTRAL-NERVOUS-SYSTEM; APPARENT DIFFUSION; TUMORS; SURVIVAL; FEATURES; CLASSIFICATION; MUTATIONS; SUBGROUPS; BIOPSY;
D O I
10.3174/ajnr.A7910
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND AND PURPOSE: Molecular profiling is a crucial feature in the "integrated diagnosis" of CNS tumors. We aimed to determine whether radiomics could distinguish molecular types of pontine pediatric high-grade gliomas that have similar/overlapping phenotypes on conventional anatomic MR images.MATERIALS AND METHODS: Baseline MR images from children with pontine pediatric high-grade gliomas were analyzed. Retrospective imaging studies included standard precontrast and postcontrast sequences and DTI. Imaging analyses included median, mean, mode, skewness, and kurtosis of the ADC histogram of the tumor volume based on T2 FLAIR and enhancement at baseline. Histone H3 mutations were identified through immunohistochemistry and/or Sanger or next-generation DNA sequencing. The log-rank test identified imaging factors prognostic of survival from the time of diagnosis. Wilcoxon rank-sum and Fisher exact tests compared imaging predictors among groups.RESULTS: Eighty-three patients had pretreatment MR imaging and evaluable tissue sampling. The median age was 6 years (range, 0.7-17 years); 50 tumors had a K27M mutation in H3-3A, and 11, in H3C2/3. Seven tumors had histone H3 K27 alteration, but the specific gene was unknown. Fifteen were H3 wild-type. Overall survival was significantly higher in H3C2/3-compared with H3-3A -mutant tumors (P = .003) and in wild-type tumors compared with any histone mutation (P = .001). Lower overall survival was observed in patients with enhancing tumors (P = .02) compared with those without enhancement. H3C2/3-mutant tumors showed higher mean, median, and mode ADC_total values (P<.001) and ADC_enhancement (P<.004), with lower ADC_total skewness and kurtosis (P<.003) relative to H3-3A-mutant tumors. CONCLUSIONS: ADC histogram parameters are correlated with histone H3 mutation status in pontine pediatric high-grade glioma.
引用
收藏
页码:833 / 840
页数:8
相关论文
共 50 条
  • [21] Differentiating high-grade from low-grade chondrosarcoma with MR imaging
    Yoo, Hye Jin
    Hong, Sung Hwan
    Choi, Ja-Young
    Moon, Kyung Chul
    Kim, Han-Soo
    Choi, Jung-Ah
    Kang, Heung Sik
    EUROPEAN RADIOLOGY, 2009, 19 (12) : 3008 - 3014
  • [22] ATM inhibition enhances the efficacy of radiation across distinct molecular subgroups of pediatric high-grade glioma
    Xie, Jia
    Kuriakose, Teneema
    Bianski, Brandon
    Twarog, Nathaniel
    Savage, Evan
    Xu, Ke
    Zhu, Xiaoyan
    He, Chen
    Hansen, Baranda
    Wang, Hong
    High, Anthony
    Li, Yuxin
    Rehg, Jerold E.
    Tillman, Heather S.
    Freeman, Burgess B.
    Rankovic, Zoran
    Onar-Thomas, Arzu
    Fan, Yiping
    Wu, Gang
    Peng, Junmin
    Miller, Shondra
    Baker, Suzanne J.
    Shelat, Anang A.
    Tinkle, Christopher L.
    NEURO-ONCOLOGY, 2023, 25 (10) : 1828 - 1841
  • [23] Poly-ADP-Ribose Polymerase as a Therapeutic Target in Pediatric Diffuse Intrinsic Pontine Glioma and Pediatric High-Grade Astrocytoma
    Chornenkyy, Yevgen
    Agnihotri, Sameer
    Yu, Man
    Buczkowicz, Pawel
    Rakopoulos, Patricia
    Golbourn, Brian
    Garzia, Livia
    Siddaway, Robert
    Leung, Stephie
    Rutka, James T.
    Taylor, Michael D.
    Dirks, Peter B.
    Hawkins, Cynthia
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (11) : 2560 - 2568
  • [24] Application of PET imaging delta radiomics for predicting progression-free survival in rare high-grade glioma
    Ahrari, Shamimeh
    Zaragori, Timothee
    Zinsz, Adeline
    Oster, Julien
    Imbert, Laetitia
    Verger, Antoine
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [25] Epigenetic programming of pediatric high-grade glioma: Pushing beyond proof of concept to clinical benefit
    Groves, Andrew
    Cooney, Tabitha M.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [26] Structural variants shape driver combinations and outcomes in pediatric high-grade glioma
    Dubois, Frank P. B.
    Shapira, Ofer
    Greenwald, Noah F.
    Zack, Travis
    Wala, Jeremiah
    Tsai, Jessica W.
    Crane, Alexander
    Baguette, Audrey
    Hadjadj, Djihad
    Harutyunyan, Ashot S.
    Kumar, Kiran H.
    Blattner-Johnson, Mirjam
    Vogelzang, Jayne
    Sousa, Cecilia
    Kang, Kyung Shin
    Sinai, Claire
    Wang, Dayle K.
    Khadka, Prasidda
    Lewis, Kathleen
    Nguyen, Lan
    Malkin, Hayley
    Ho, Patricia
    O'Rourke, Ryan
    Zhang, Shu
    Gold, Rose
    Deng, Davy
    Serrano, Jonathan
    Snuderl, Matija
    Jones, Chris
    Wright, Karen D.
    Chi, Susan N.
    Grill, Jacques
    Kleinman, Claudia L.
    Goumnerova, Liliana C.
    Jabado, Nada
    Jones, David T. W.
    Kieran, Mark W.
    Ligon, Keith L.
    Beroukhim, Rameen
    Bandopadhayay, Pratiti
    NATURE CANCER, 2022, 3 (08) : 994 - +
  • [27] Association between extent of resection on survival in adult brainstem high-grade glioma patients
    Doyle, Joshua
    Khalafallah, Adham M.
    Yang, Wuyang
    Sun, Yi
    Bettegowda, Chetan
    Mukherjee, Debraj
    JOURNAL OF NEURO-ONCOLOGY, 2019, 145 (03) : 479 - 486
  • [28] Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma
    Sewing, A. Charlotte P.
    Lagerweij, Tonny
    van Vuurden, Dannis G.
    Meel, Michael H.
    Veringa, Susanna J. E.
    Carcaboso, Angel M.
    Gaillard, Pieter J.
    Vandertop, W. Peter
    Wesseling, Pieter
    Noske, David
    Kaspers, Gertjan J. L.
    Hulleman, Esther
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2017, 19 (05) : 518 - 530
  • [29] Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma
    Rosenberg, Tom
    Yeo, Kee Kiat
    Mauguen, Audrey
    Alexandrescu, Sanda
    Prabhu, Sanjay P.
    Tsai, Jessica W.
    Malinowski, Seth
    Joshirao, Mrinal
    Parikh, Karishma
    Sait, Sameer Farouk
    Rosenblum, Marc K.
    Benhamida, Jamal K.
    Michaiel, George
    Tran, Hung N.
    Dahiya, Sonika
    Kachurak, Kara
    Friedman, Gregory K.
    Krystal, Julie, I
    Huang, Michael A.
    Margol, Ashley S.
    Wright, Karen D.
    Aguilera, Dolly
    MacDonald, Tobey J.
    Chi, Susan N.
    Karajannis, Matthias A.
    NEURO-ONCOLOGY, 2022, 24 (11) : 1964 - 1975
  • [30] ADC texture-An imaging biomarker for high-grade glioma?
    Brynolfsson, Patrik
    Nilsson, David
    Henriksson, Roger
    Hauksson, Jon
    Karlsson, Mikael
    Garpebring, Anders
    Birgander, Richard
    Trygg, Johan
    Nyholm, Tufve
    Asklund, Thomas
    MEDICAL PHYSICS, 2014, 41 (10)